In what is likely a precursor to the Food and Drug Administration taking regulatory action on low testosterone replacement therapy (TRT), the FDA has asked two advisory committees to meet on September 17 to evaluate the risks and reported testosterone side effects linked to so-called “Low T” drugs, such as AndroGel, Testim,... Read more »

All testosterone therapy lawsuits filed in U.S. District Courts nationwide, alleging injuries because of Low T treatments, will now go before one judge in the Northern District of Illinois in centralized litigation known as “multidistrict litigation” or MDL. This move comes on the heels of June 6 order by a... Read more »

The makers of several testosterone supplements are facing an impending class action lawsuit filed in California District Court early last month. The testosterone class action lawsuit raises several counts against manufacturers of over-the-counter products containing the chemical Testofen and asserts many of the claims made by these manufacturers are bogus, exaggerated... Read more »

In the face of compelling evidence that “Low T therapy,” testosterone producing drugs increase chances of strokes and heart attacks, doctors with apparent vested ties to the industry are now claiming the opposite: that such drugs actually help prevent heart attacks. After it recently formed to take on “unnecessary” concerns... Read more »

As the number of testosterone therapy lawsuits continues to rise nationwide, efforts to coordinate the litigation have met with a minor snag. While most companies listed as defendants on these cases agree coordination of litigation is the best choice, one manufacturer of testosterone treatment, is opposing the move. How this... Read more »